Mesoblast | MSB - Cost Of Sales

Stock Price
2.23
Daily Change
-0.16 -6.69%
Monthly
-18.32%
Yearly
-28.75%
Q1 Forecast
2.48

Mesoblast reported $19.87M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Avita Medical AUD 3.47M 1.19M Jun/2025
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Cochlear AUD 158.85M 131.25M Jun/2025
CSL USD 1.79B 2.15B Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Ramsay Health Care AUD 2.98B 742.1M Jun/2025
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Starpharma Holdings AUD 876K 528K Jun/2025
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024